Surprise leadership change at Affitech
This article was originally published in Scrip
Executive Summary
The Norwegian company Affitech, which recently merged with Pharmexa of Denmark through a reverse acquisition, has made unexpected changes to its leadership through the appointment of Dr Robert Burns as its new chief executive and Dr Alexander Duncan as senior vice-president of R&D.